MNIA Cannis Inc (CE)

MNI Nutraceuticals (PINKSHEETS: MNIA) is pleased to announce that it is expanding its core products beyond the joint pain and weight management categories that have been the cornerstone of MNI Nutraceuticals. Currently, Arthrizyme and Vital Slim has been a strong mainstay for MNI as Arthrizyme has been a continued success with its joint pain benefits and is still in strong demand with Vital Slim having created a niche in the billion dollar weight management sector. MNI feels it is time to begin diversifying beyond the joint pain and weight control markets.

MNI has been heavily researching on various delivery systems and technologies that will impact the marketplace, similar to how Arthrizyme did on its introduction back in 2004. Stated Mr. Harvey Panesar, President of MNI Nutraceuticals: "MNI has spent a great degree of time looking at various delivery platforms and technologies for the natural supplementation market that will definitely change the way the natural food market is viewed. We have spent numerous amounts of hours determining where the market is, and where it is going, from RTD (ready-to-drink), Mood/Mind Health food and drinks, gluten-free products, food and beverage additives, as well as anti-oxidants and probiotics. Each of these categories has a year over year growth with expectations of annual sales of over $1 billion."

Mr. Panesar continued, "Not only have we been looking at other categories under the natural food marketplace, we have been seeking various delivery platforms as well. From functional gum, to trans-dermal patches, to additive drops, we have been looking at expanding the MNI brand to continue being a category leader."

About MNI Nutraceuticals Inc.

MNI Nutraceuticals Inc. is a company focused on providing a better health and lifestyle through natural products. MNI Nutraceuticals flagship products include Arthrizyme™ for general joint pain and Vital Slim, which is a proprietary formula for weight control and management. For more information please visit: www.mninutra.com

Safe Harbor Statement

This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The risks and uncertainties that may affect the operations, performance development and results of the Company's business include but are not limited to fluctuations in financial results, availability and customer acceptance of our products and services, the impact of competitive products, services and pricing, general market trends and conditions.

Contact: Taylor Capitol, Inc. Investor Relations: Stephen Taylor 973-351-3868 E-mail: Email Contact